Onconetix, Inc.
ONCO
$0.0761
-$0.0039-4.88%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 25.90% | 66.90% | 60.55% | 46.30% | 38.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.78% | 30.09% | 24.56% | 23.74% | 26.69% |
| Operating Income | -0.16% | -18.93% | -19.12% | -23.28% | -26.69% |
| Income Before Tax | -183.11% | -216.77% | -222.74% | -178.86% | -60.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -182.35% | -216.27% | -221.80% | -178.76% | -60.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -182.35% | -216.27% | -221.80% | -178.76% | -60.25% |
| EBIT | -0.16% | -18.93% | -19.12% | -23.28% | -26.69% |
| EBITDA | 4.54% | -15.57% | -17.40% | -23.01% | -26.70% |
| EPS Basic | -114.64% | -143.20% | -140.42% | -79.07% | 20.12% |
| Normalized Basic EPS | 47.09% | 20.93% | 20.47% | 27.96% | 31.04% |
| EPS Diluted | -114.64% | -143.20% | -140.42% | -79.07% | 20.12% |
| Normalized Diluted EPS | 47.09% | 20.93% | 20.47% | 27.96% | 31.04% |
| Average Basic Shares Outstanding | 76.40% | 29.74% | 27.67% | 39.90% | 82.79% |
| Average Diluted Shares Outstanding | 76.40% | 29.74% | 27.67% | 39.90% | 82.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |